Lin, Pei
The University of Texas MD Anderson Cancer Center,
United States
2025 Rank: 273,600
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Immunology
Rank in SubField 1: 366 out of 25,326 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 273,600 | 281,537 |
| Total Cites | 641 | 719 |
| H-index | 11 | 12 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 45 | 46 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 101 | 105 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 544 | 587 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.22 |
| Self-Citation Percentage |
10.85%
|
|
Lin, Pei
The University of Texas MD Anderson Cancer Center,
United States
2024 Rank: 202,068
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Immunology
Rank in SubField 1: 295 out of 24,457 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 202,068 | 210,650 |
| Total Cites | 667 | 763 |
| H-index | 11 | 11 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 39 | 41 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 83 | 96 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 556 | 603 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.27 |
| Self-Citation Percentage |
12.58%
|
|
Lin, Pei
The University of Texas MD Anderson Cancer Center,
United States
2023 Rank: 244,173
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Immunology
Rank in SubField 1: 411 out of 23,576 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 244,173 | 250,336 |
| Total Cites | 592 | 677 |
| H-index | 11 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 60 | 64 |
| Number of Single+First+Last Authored Papers | 61 | 61 |
| Total Cites to Single+First+Last Authored Papers | 111 | 121 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 496 | 538 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.26 |
| Self-Citation Percentage |
12.56%
|
|
Lin, Pei
University of Texas MD Anderson Cancer Center,
United States
2022 Rank: 236,712
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Immunology
Rank in SubField 1: 416 out of 23,010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 236,712 | 256,470 |
| Total Cites | 610 | 697 |
| H-index | 10 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 53 | 56 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 121 | 127 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 511 | 560 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.24 |
| Self-Citation Percentage |
12.48%
|
|
Lin, Pei
University of Texas MD Anderson Cancer Center,
United States
2021 Rank: 220,698
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Immunology
Rank in SubField 1: 417 out of 22,656 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 220,698 | 216,093 |
| Total Cites | 925 | 1,082 |
| H-index | 13 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 91 | 100 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 188 | 209 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 779 | 857 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.26 |
| Self-Citation Percentage |
14.51%
|
|
Lin, Pei
University of Texas MD Anderson Cancer Center,
United States
2020 Rank: 171,019
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Immunology
Rank in SubField 1: 316 out of 19,713 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 171,019 | 175,948 |
| Total Cites | 644 | 780 |
| H-index | 11 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 78 | 89 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 136 | 161 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 540 | 606 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.29 |
| Self-Citation Percentage |
17.44%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.